A new topical retinoid - Why a new topical acne therapy?

British Journal of Dermatology, Supplement

Volumn 139, Issue 52, 1998, Pages 1-2

  Cunliffe, W J ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; ISOTRETINOIN; RETINOID DERIVATIVE;

ACNE; DERMATITIS; HUMAN; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; SEBACEOUS GLAND; SHORT SURVEY; SKIN IRRITATION; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0031690939     PISSN: 0366077X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.1390s2001.x     Document Type: Short Survey

References (14)

1. Eady EA, Cove JH, Jones DN, CunlifTe \V. Topical antibiotics for the treatment of acne vulgaris: a critical evaluation of the literature on their clinical benefit and comparative efficacy. J Dcrmatol Treatment 1990; 1: 215-16.
2. Strauss JA, Rapini RP. Shalita AR et al Isotrctinoin therapy for acne: results of a multicentre dose-response study. J Acad Dermatol 1994; 10: 490-6.
3. Thiboutot D, Harris G, Iles V et al Activity of the type l, 5-alpha reductase exhibits regional differences in isolated sebaceous glands and whole skin. J Invest Dermaiol 1995; 105: 209-14.
4. Thiboutot DM, Knaggs H, Gilliland K et al. Activity of type 1, 5areductase is greater in the follicular infrainfundibulum compared with the epidermis. Br J Dermatol 1997; 136: 166-71.
5. Verschoore M, Langner A, \Volska H et al Efficacy and safety of CD271 alcoholic gels in topical treatment of acne vulgaris. Br J Dermatol 1991; 124: 368-71.
6. King K, Jones DH, Daltry DC, Cunlifie WJ. Double-blind study of the effects of 13-cis-retinoic acid on acne, sebum excretion rate and microbial population. Br J Dermatol 1982; 107: 583-90.
7. Lucky AW, Bifo FN, Hustar EA et al Acne vulgaris in premenarchal girls. Arch Dermatol 1994; 130: 308-14.
8. Eady EA, Ingham E, Walters CE et al Modulation of comedonal levels of interleukin-1 in acne patients treated with tetracyclines. J Invest Dermatol 1993; 101: 86-91.
9. Webster GF, Leyden JJ, McGinley M et al Suppression of polymorphonuclear leucocyte chemotactic factor production in Propionibacteriwn acnes by sub-minimal inhibitory concentrations of tetracycline, ampicillin, minocycline and erythromycin. Antlmicrob Agents Chemother 1982; 21: 770-7.
10. Eady EA, Cove JH, Holland KT, Cunlifie WL. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol 1989; 121: 51-7.
11. Allée J, Chatelus A, Wagner N. Skin distribution and pharmaceutical aspects of adapalene gel. J Aili Acad Dermatol 1997; 36: S119-25.
12. Shroot B, Michel S. Pharmacology and chemistry of adapalene. J Am Acad Dermatol 1997; 36: S96-103.
13. Verschoore M, Poncet M et al Adapalene 0-1% gel has low skin irritation potential. J Am Acad Dermatol 1997; 36: S104-9.
14. Caron D, Sorba V et al Skin tolerance of adapalene 0-1% gel in combination with other topical anti-acne treatments. J Am Acad Dermatol 1997; 36: S113-15.